Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Anke Van der Perren
Based on 10 articles published since 2009
(Why 10 articles?)
||||
Expertise Level
The expertise of Anke Van der Perren ranks in the
  • Top 3%
  • ... of 70,737 published authors worldwide on Parkinson Disease
  • ... from 2009 through 2019
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Aliases Van der Perren, Anke   ·   Van der Perren, A   ·   van der Perren, Anke
Work Locations
Details
Most likely:    Katholieke Universiteit Leuven      
2018
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Pubmed 29850629
  • Division of Nuclear Medicine, Department of Imaging and Pathology, KU Leuven and University Hospital Leuven, Leuven, Belgium; MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium. · MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium; Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium. · MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium; Biomedical MRI Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. · Division of Nuclear Medicine, Department of Imaging and Pathology, KU Leuven and University Hospital Leuven, Leuven, Belgium; MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium. Electronic address: · Pubmed 29055799
2016
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven. · Division of Nuclear Medicine, Leuven University Hospital - KU Leuven. · Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven; Leuven Viral Vector Core, KU Leuven. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven; Leuven Viral Vector Core, KU Leuven. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven; · Pubmed 26967677
2015
  • Katholieke Universiteit Leuven, Leuven, Belgium, · Pubmed 24839101
  • KU Leuven, Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, 3000 Leuven, Belgium. · Paris-Saclay Institute of Neuroscience, CNRS, Avenue de la Terrasse, 91198 Gif-sur-Yvette, France. · Theoretical Neurobiology &Neuroengineering Laboratory, Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium. · 1] Theoretical Neurobiology &Neuroengineering Laboratory, Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium [2] Department of Computer Science, University of Sheffield, S1 4DP Sheffield, UK [3] Brain Mind Institute, Swiss Federal Institute of Technology of Lausanne, 1015 Lausanne, Switzerland [4] Neuro-Electronics Research Flanders (NERF), 3001 Leuven, Belgium. · 1] KU Leuven, Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, 3000 Leuven, Belgium [2] KU Leuven, Leuven Viral Vector Core, 3000 Leuven, Belgium. · Pubmed 26061766
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium. · Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Belgium. · Division of Nephrology and Renal Transplantation, Department of Microbiology and Immunology, Leuven University Hospital and KU Leuven, Leuven, Belgium. · Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. Electronic address: · Pubmed 25660193
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium. · Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Belgium. · Division of Nuclear Medicine, Leuven University Hospital and KU Leuven, Leuven, Belgium. · Department of Pharmaceutical Chemistry and Drug Analysis, Vrije Universiteit Brussel, Brussel, Belgium. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany; Department of Psychiatry, University of California San Diego, San Diego, USA. · Biomedical MRI Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. · Laboratory of Biological Psychology, Department of Psychology, KU Leuven, Leuven, Belgium. · Laboratory for Radiopharmacy, Department of Pharmaceutical en Pharmacological Sciences, KU Leuven, Belgium. · Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. Electronic address: · Pubmed 25599874
2014
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Laboratory of Biochemistry, Interdisciplinary Research Centre KU Leuven-Kortrijk, Kortrijk, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium. Electronic address: · Pubmed 25037286
2013
  • Department of Neurosciences and Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven, Laboratory for Neurobiology and Gene Therapy, Kapucijnenvoer 33, box 7001, 3000 Leuven, Belgium. · Pubmed 24267638
Possible:    Freie Universitat      
2013
  • 1] Institute of Molecular Biosciences, University of Graz, Graz, Austria [2] Institute for Biology/Genetics, Freie Universität Berlin, Berlin, Germany. · Pubmed 24129513
Possible:    Universitat Graz      
2013
  • 1] Institute of Molecular Biosciences, University of Graz, Graz, Austria [2] Institute for Biology/Genetics, Freie Universität Berlin, Berlin, Germany. · Pubmed 24129513
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Anke Van der Perren in 2009-2019 about Parkinson Disease:

  • Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease. 2018
  • Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia. 2018
  • Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector. 2016
  • Viral vector-based models of Parkinson's disease. 2015
  • α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. 2015
  • FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease. 2015
  • Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors. 2015
  • Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice. 2014
  • rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration. 2013
  • Endonuclease G mediates α-synuclein cytotoxicity during Parkinson's disease. 2013
Show List of Full Article Records
Google Searches

Learn more about Anke Van der Perren using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Katholieke Universiteit Leuven
Freie Universitat
Universitat Graz
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Katholieke Universiteit Leuven
2018
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Pubmed 29850629
  • Division of Nuclear Medicine, Department of Imaging and Pathology, KU Leuven and University Hospital Leuven, Leuven, Belgium; MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium. · MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium; Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium. · MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium; Biomedical MRI Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. · Division of Nuclear Medicine, Department of Imaging and Pathology, KU Leuven and University Hospital Leuven, Leuven, Belgium; MoSAIC - Molecular Small Animal Imaging Centre, KU Leuven, Leuven, Belgium. Electronic address: · Pubmed 29055799
2016
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven. · Division of Nuclear Medicine, Leuven University Hospital - KU Leuven. · Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven; Leuven Viral Vector Core, KU Leuven. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven; Leuven Viral Vector Core, KU Leuven. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven; · Pubmed 26967677
2015
  • Katholieke Universiteit Leuven, Leuven, Belgium, · Pubmed 24839101
  • KU Leuven, Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, 3000 Leuven, Belgium. · Paris-Saclay Institute of Neuroscience, CNRS, Avenue de la Terrasse, 91198 Gif-sur-Yvette, France. · Theoretical Neurobiology &Neuroengineering Laboratory, Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium. · 1] Theoretical Neurobiology &Neuroengineering Laboratory, Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium [2] Department of Computer Science, University of Sheffield, S1 4DP Sheffield, UK [3] Brain Mind Institute, Swiss Federal Institute of Technology of Lausanne, 1015 Lausanne, Switzerland [4] Neuro-Electronics Research Flanders (NERF), 3001 Leuven, Belgium. · 1] KU Leuven, Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, 3000 Leuven, Belgium [2] KU Leuven, Leuven Viral Vector Core, 3000 Leuven, Belgium. · Pubmed 26061766
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium. · Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Belgium. · Division of Nephrology and Renal Transplantation, Department of Microbiology and Immunology, Leuven University Hospital and KU Leuven, Leuven, Belgium. · Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. Electronic address: · Pubmed 25660193
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium. · Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Belgium. · Division of Nuclear Medicine, Leuven University Hospital and KU Leuven, Leuven, Belgium. · Department of Pharmaceutical Chemistry and Drug Analysis, Vrije Universiteit Brussel, Brussel, Belgium. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany. · Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany; Department of Psychiatry, University of California San Diego, San Diego, USA. · Biomedical MRI Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. · Laboratory of Biological Psychology, Department of Psychology, KU Leuven, Leuven, Belgium. · Laboratory for Radiopharmacy, Department of Pharmaceutical en Pharmacological Sciences, KU Leuven, Belgium. · Laboratory for Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Flanders, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. Electronic address: · Pubmed 25599874
2014
  • Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium. · Laboratory of Biochemistry, Interdisciplinary Research Centre KU Leuven-Kortrijk, Kortrijk, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium; Leuven Viral Vector Core, KU Leuven, Leuven, Belgium. · Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium. Electronic address: · Pubmed 25037286
2013
  • Department of Neurosciences and Leuven Research Institute for Neuroscience and Disease (LIND), KU Leuven, Laboratory for Neurobiology and Gene Therapy, Kapucijnenvoer 33, box 7001, 3000 Leuven, Belgium. · Pubmed 24267638
Freie Universitat
2013
  • 1] Institute of Molecular Biosciences, University of Graz, Graz, Austria [2] Institute for Biology/Genetics, Freie Universität Berlin, Berlin, Germany. · Pubmed 24129513
Universitat Graz
2013
  • 1] Institute of Molecular Biosciences, University of Graz, Graz, Austria [2] Institute for Biology/Genetics, Freie Universität Berlin, Berlin, Germany. · Pubmed 24129513
Yearly article counts 02014120000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.